Clinicians' Probability Calculator to Convert Pre-Test to Post-Test Probability of SARS-CoV-2 Infection Based on Method Validation from Each Laboratory [0.03%]
基于每家实验室方法学验证的临床医生冠状病毒病2019感染先验概率转后验概率计算工具
Zoe Brooks,Saswati Das,Tom Pliura
Zoe Brooks
Background: Despite best efforts, false positive and false negative test results for SARS-CoV-2 are unavoidable. Likelihood ratios convert a clinical opinion of pre-test probability to post-test probability, independently...
Predictive Model of Severity in SARS CoV-2 Patients at Hospital Admission Using Blood-Related Parameters [0.03%]
基于血液相关参数的新冠肺炎患者入院病情 severity 预测模型
Laura Criado Gómez,Santiago Villanueva Curto,Maria Belén Pérez Sebastian et al.
Laura Criado Gómez et al.
Introduction: Blood test alterations are crucial in SARS CoV-2 (COVID-19) patients. Blood parameters, such as lymphocytes, C reactive protein (CRP), creatinine, lactate dehydrogenase, or D-dimer, are associated with sever...
Adil I Khan,Mazeeya Khan,Rosy Tirimacco
Adil I Khan
The ease of performing a laboratory test near to the patient, at the point-of-care, has resulted in the integration of point-of-care tests into healthcare treatment algorithms. However, their importance in patient care necessitates regular ...
Lessons Learned from the COVID-19 Pandemic: Emphasizing the Emerging Role and Perspectives from Artificial Intelligence, Mobile Health, and Digital Laboratory Medicine [0.03%]
从COVID-19大流行中吸取的教训：强调人工智能、移动健康和数字实验室医学的新兴作用和观点
Pradeep Kumar Dabla,Damien Gruson,Bernard Gouget et al.
Pradeep Kumar Dabla et al.
SARS-CoV-2, the new coronavirus causing COVID-19, is one of the most contagious disease of past decades. COVID-19 is different only in that everyone is encountering it for the first time during this pandemic. The world has gone from complet...
Review
EJIFCC. 2021 Jun 29;32(2):224-243. DOI: 2021
Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay [0.03%]
迪赛龙LIAISON SARS-CoV-2抗原化学发光免疫分析临床评价研究
Gian Luca Salvagno,Gianluca Gianfilippi,Giacomo Fiorio et al.
Gian Luca Salvagno et al.
Background: Due to the large volume of tests needed in a relatively short time for screening and diagnosing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, antigen immunoassays may provide a potent...
Direct to Consumer Laboratory Testing (DTCT) - Opportunities and Concerns [0.03%]
直接面向消费者的实验室检测(DTC-LT)的机会与挑战
Matthias Orth
Matthias Orth
Direct to consumer laboratory testing has the potential for self-empowerment of patients. However, the Direct to consumer laboratory testing (DTCT) uses loopholes which are related to the particular situation of healthcare: While advertisem...
Review
EJIFCC. 2021 Jun 29;32(2):209-215. DOI: 2021
Sergio Bernardini,Massimo Pieri,Marco Ciotti
Sergio Bernardini
Point of care testing (POCT) represents an important step forward in the clinical management of patients. POC assays are easy to use and do not require skilled personnel; therefore they are particularly useful in low resource settings where...
Review
EJIFCC. 2021 Jun 29;32(2):200-208. DOI: 2021
Prasenjit Mitra,Praveen Sharma
Prasenjit Mitra
Point of Care Technology (POCT) means acquiring clinical parameters from the place where the patient is, thus generating faster test results leading to a faster turnaround time. However, improvements in patient outcomes depend on how health...
Review
EJIFCC. 2021 Jun 29;32(2):195-199. DOI: 2021
Rajiv Erasmus,Sumedha Sahni,Rania El-Sharkawy
Rajiv Erasmus
Point of Care Testing is increasingly being used for diagnosis and management of various disease states. Management of different Point of Care instruments at multiple sites can be challenging, particularly when such instruments are operated...
Review
EJIFCC. 2021 Jun 29;32(2):190-194. DOI: 2021
Leading POCT Networks: Operating POCT Programs Across Multiple Sites Involving Vast Geographical Areas and Rural Communities [0.03%]
引领POCT网络化运营：多网点、广区域和农村社区的管理挑战
Edward W Randell,Vinita Thakur
Edward W Randell
Few peer-reviewed publications provide laboratory leaders with useful strategies on which to develop and implement point of care testing (POCT) programs to support delivery of acute care services to remote rural communities, with or without...
Review
EJIFCC. 2021 Jun 29;32(2):179-189. DOI: 2021